Avalo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.About AVTX
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.
CEOGarry Arthur Neil
CEOGarry Arthur Neil
Employees33
Employees33
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2011
Founded2011
Employees33
Employees33
AVTX Key Statistics
Market cap1.12B
Market cap1.12B
Price-Earnings ratio-4.17
Price-Earnings ratio-4.17
Dividend yield—
Dividend yield—
Average volume823.32K
Average volume823.32K
High today$19.89
High today$19.89
Low today$18.98
Low today$18.98
Open price$19.67
Open price$19.67
Volume195.09K
Volume195.09K
52 Week high$24.27
52 Week high$24.27
52 Week low$8.29
52 Week low$8.29
Stock Snapshot
Avalo Therapeutics(AVTX) stock is priced at $19.06, giving the company a market capitalization of 1.12B. It carries a P/E multiple of -4.17.
On 2026-08-11, Avalo Therapeutics(AVTX) stock traded between a low of $18.98 and a high of $19.89. Shares are currently priced at $19.06, which is +0.4% above the low and -4.1% below the high.
The Avalo Therapeutics(AVTX)'s current trading volume is 195.09K, compared to an average daily volume of 823.32K.
In the last year, Avalo Therapeutics(AVTX) shares hit a 52-week high of $24.27 and a 52-week low of $8.29.
In the last year, Avalo Therapeutics(AVTX) shares hit a 52-week high of $24.27 and a 52-week low of $8.29.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AVTX. This list is generated using Robinhood data, and it’s not a recommendation.